Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
04-07 March, 2025
Not Confirmed
Not Confirmed
05-07 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
04-07 March, 2025
Industry Trade Show
Not Confirmed
05-07 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
08 Apr 2023
// BIOSPECTRUM ASIA
https://www.biospectrumasia.com/news/30/22255/cepi-appoints-dr-yasuhiro-suzuki-to-the-board.html
27 Oct 2022
// PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/sk-bioscience-cepi-vaccine-deal/
26 Oct 2022
// INDIANPHARMAPOST
https://www.indianpharmapost.com/news/cepi-and-sk-bioscience-partner-to-advance-mrna-vaccine-technology-13207
06 Oct 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cepi-partners-with-intravacc-to-develop-an-intranasal-broadly-protective-betacoronavirus-vaccine-301641943.html
05 Jul 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/07/05/2473809/0/en/CEPI-and-Codiak-BioSciences-partner-to-develop-broadly-protective-Betacoronavirus-vaccine.html
06 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/06/2418030/0/en/CEPI-to-co-fund-Vaxxinity-s-pivotal-Phase-3-UB-612-heterologous-booster-trial-to-combat-SARS-CoV-2-variants.html
ABOUT THIS PAGE